Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win Read more
Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod Read more
Regeneron ends eye disease trial for anti-CD3 antibody following safety review Read more
December 3, 2025 @ 12:00 am

This high-impact life sciences conference provides a unique platform for insightful discussions, deal-making, and strategic networking—all designed to accelerate the translation of cutting-edge science into real-world patient benefits.
Gain insights from industry pioneers through thought-provoking plenary talks and panel discussions, connect with potential collaborators, investors, and decision-makers to foster new partnerships and explore innovative solutions from leading providers supporting the life sciences sector.
Last year’s Genesis conference attracted 300+ high-level delegates, facilitating critical conversations that drive the industry forward. Whether you’re a biotech entrepreneur, investor, or executive, Genesis 2025 is your chance to stay at the forefront of emerging trends, market shifts, and technological advancements.